Scarica l'app Stockscreener
33.70
1.63%
0.54
Dopo l'orario di chiusura:
33.70
Precedente Chiudi:
$33.16
Aprire:
$33
Volume 24 ore:
1.24M
Relative Volume:
1.33
Capitalizzazione di mercato:
$3.62B
Reddito:
-
Utile/perdita netta:
$-167.80M
Rapporto P/E:
-20.65
EPS:
-1.6323
Flusso di cassa netto:
$-144.07M
1 W Prestazione:
+2.00%
1M Prestazione:
+13.89%
6M Prestazione:
+115.75%
1 anno Prestazione:
+158.83%
Intervallo 1D:
$32.57
$33.91
Intervallo di 1 settimana:
$32.26
$34.77
Portata 52W:
$12.15
$34.77
Edgewise Therapeutics Inc Stock (EWTX) Company Profile
Nome
Edgewise Therapeutics Inc
Settore
Industria
Telefono
720-262-7002
Indirizzo
1715 38TH ST, BOULDER
Compare EWTX vs VRTX, REGN, ARGX, ALNY, ONC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
EWTX
Edgewise Therapeutics Inc
|
33.70 | 3.56B | 0 | -167.80M | -144.07M | -1.6323 |
VRTX
Vertex Pharmaceuticals Inc
|
441.70 | 113.01B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
753.93 | 79.87B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
840.87 | 51.51B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
333.39 | 45.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
319.94 | 34.41B | 5.36B | 287.73M | 924.18M | 2.5229 |
Edgewise Therapeutics Inc Stock (EWTX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-09-25 | Iniziato | Goldman | Neutral |
| 2025-07-30 | Iniziato | Raymond James | Strong Buy |
| 2025-06-30 | Iniziato | H.C. Wainwright | Buy |
| 2025-04-30 | Iniziato | Guggenheim | Buy |
| 2025-04-02 | Downgrade | Scotiabank | Sector Outperform → Sector Perform |
| 2025-03-07 | Iniziato | Scotiabank | Sector Outperform |
| 2025-01-22 | Iniziato | Stifel | Hold |
| 2024-11-22 | Iniziato | Evercore ISI | Outperform |
| 2024-03-07 | Iniziato | Piper Sandler | Overweight |
| 2023-05-01 | Iniziato | Truist | Buy |
| 2022-08-25 | Downgrade | Goldman | Neutral → Sell |
| 2022-04-13 | Iniziato | RBC Capital Mkts | Outperform |
| 2022-01-28 | Iniziato | Goldman | Neutral |
Mostra tutto
Edgewise Therapeutics Inc Borsa (EWTX) Ultime notizie
Edgewise Therapeutics stock hits 52-week high at 34.03 USD - Investing.com
Edgewise Therapeutics stock hits 52-week high at 34.03 USD By Investing.com - Investing.com India
Retail Surge: Can Edgewise Therapeutics Inc expand its profit marginsTrade Performance Summary & Risk Managed Trade Strategies - baoquankhu1.vn
Analysts Bullish on Edgewise Therapeutics Stock - National Today
Bull Run: Will Edgewise Therapeutics Inc stock hit new highs in YEAR2026 Geopolitical Influence & Safe Entry Point Identification - baoquankhu1.vn
Behavioral Patterns of EWTX and Institutional Flows - Stock Traders Daily
Ideas Watch: Will Edgewise Therapeutics Inc stock hit new highs in YEARInsider Selling & Verified Short-Term Trading Plans - baoquankhu1.vn
History Review: Will Edgewise Therapeutics Inc stock hit new highs in YEAR2026 Opening Moves & Smart Investment Allocation Tips - baoquankhu1.vn
Aug Rallies: Can Edgewise Therapeutics Inc grow without dilutionWeekly Loss Report & Community Trade Idea Sharing Platform - baoquankhu1.vn
Edgewise Therapeutics (NASDAQ:EWTX) Reaches New 12-Month HighShould You Buy? - MarketBeat
Aberdeen Group plc Increases Position in Edgewise Therapeutics, Inc. $EWTX - MarketBeat
Aug Wrap: Is Edgewise Therapeutics Inc a cyclical or defensive stockMarket Activity Report & Weekly Stock Breakout Alerts - baoquankhu1.vn
Update Recap: Can Edgewise Therapeutics Inc reach all time highs this year2026 Investor Takeaways & Free Expert Verified Stock Movement Alerts - baoquankhu1.vn
Why Edgewise Therapeutics (EWTX) Is Up 8.1% After New Sevasemten BMD Data And Analyst Interest - Sahm
Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Given Consensus Recommendation of "Moderate Buy" by Analysts - MarketBeat
Edgewise Therapeutics (EWTX) Valuation After Positive Becker Muscular Dystrophy Extension Data - Sahm
Breakouts Watch: Is Edgewise Therapeutics Inc subject to activist investor interest2026 Action & Free Technical Pattern Based Buy Signals - baoquankhu1.vn
SG Americas Securities Boosts Stake in Edgewise Therapeutics - National Today
SG Americas Securities LLC Buys 78,842 Shares of Edgewise Therapeutics, Inc. $EWTX - MarketBeat
Breakout Move: Is Edgewise Therapeutics Inc being accumulated by smart moneyMarket Performance Summary & Daily Technical Forecast Reports - baoquankhu1.vn
Director at Edgewise Therapeutics (EWTX) awarded 339 new shares - Stock Titan
Edgewise Therapeutics stock hits 52-week high at 33.5 USD By Investing.com - Investing.com Canada
Edgewise Therapeutics, Inc. (EWTX) PT increased to $45 at JPMorgan amid optimism on EDG-7500 pipeline - MSN
Edgewise Therapeutics (NASDAQ:EWTX) CMO Joanne Donovan Sells 28,662 Shares - MarketBeat
Edgewise Therapeutics CMO sells $926,095 in EWTX stock By Investing.com - Investing.com Canada
Edgewise Therapeutics Insider Sold Shares Worth $926,095, According to a Recent SEC Filing - marketscreener.com
[Form 4] Edgewise Therapeutics, Inc. Insider Trading Activity - Stock Titan
Edgewise Therapeutics stock hits 52-week high at 33.5 USD - Investing.com
Edgewise Therapeutics (NASDAQ:EWTX) Sets New 52-Week HighHere's What Happened - MarketBeat
Hedge Fund Bets: Is Edgewise Therapeutics Inc exposed to currency risksQuarterly Market Summary & Stepwise Trade Signal Implementation - baoquankhu1.vn
Edgewise Therapeutics Reports Inducement Grants as Permitted by the Nasdaq Listing Rules - 富途牛牛
Edgewise Therapeutics Reports Inducement Grants as permitted by the Nasdaq Listing Rules - ChartMill
EWTX PE Ratio & Valuation, Is EWTX Overvalued - Intellectia AI
Edgewise Therapeutics CMO sells $685k in EWTX stock By Investing.com - Investing.com Canada
Edgewise Therapeutics (EWTX) CMO sells 21,338 shares after option exercise - Stock Titan
Fund Flows: Is Edgewise Therapeutics Inc trading at a discount2026 Intraday Action & Accurate Entry and Exit Point Alerts - baoquankhu1.vn
Insider Sell Alert: Joanne Donovan Sells 16,358 Shares of Edgewi - GuruFocus
Insider Sell Alert: Joanne Donovan Sells 16,358 Shares of Edgewise Therapeutics Inc (EWTX) - GuruFocus
Edgewise Therapeutics CMO Donovan sells $506k in EWTX stock By Investing.com - Investing.com Canada
Edgewise Therapeutics (NASDAQ: EWTX) CMO sells 16,358 shares in open market - Stock Titan
Edgewise Therapeutics, Inc. (EWTX) PT Increased to $45 at JPMorgan Amid Optimism on EDG-7500 Pipeline - Yahoo Finance
EWTX Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
(EWTX) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
EWTX (NASDAQ) Form 144 lists 71,588 shares from options, ESPP, RSUs - stocktitan.net
Aug Analyst Calls: Can Edgewise Therapeutics Inc reach all time highs this year2026 Major Catalysts & Low Risk High Win Rate Stock Picks - baoquankhu1.vn
Edgewise Therapeutics stock reaches 52-week high at $31.86 By Investing.com - Investing.com Australia
Edgewise Therapeutics stock reaches 52-week high at $31.86 - Investing.com
Why Edgewise Therapeutics Stock Topped the Market on Tuesday - AOL.com
A Look At Edgewise Therapeutics (EWTX) Valuation After Promising Sevasemten Becker Muscular Dystrophy Data - Sahm
EWTX SEC FilingsEdgewise Therapeutics, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan
Edgewise Therapeutics team to attend 2026 American College of Cardiology annual meeting - Traders Union
Edgewise Therapeutics Inc Azioni (EWTX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.69%
0.25%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):